Hims & Hers shares gain more than 4% after strong Q2 earnings and Novo Nordisk partnership

Traders Union
All News
Stocks
Hims & hers rises 4.16% today

Highlights

Hims & Hers stock advanced after reporting strong second-quarter results and issuing an updated financial outlook.
The company entered a strategic partnership with Novo Nordisk during a period of increased market attention.
Shares trade above short- and long-term support, but momentum readings are mixed and consolidation near $30.26 to $31.63 is likely, with an 80% probability of a move down to $28.69.

Sentiment shifts as partnership and strong results drive investor focus

Hims & Hers released strong second-quarter results and updated its financial outlook. The company also entered a strategic partnership with Novo Nordisk. These developments follow increased attention from the market.

Anton Kharitonov, expert at Traders Union, sees the current rally in Hims & Hers as fragile despite recent bullish news and positive guidance. He notes that persistent medium-term selling pressure and mixed momentum signals undermine the sustainability of gains. Multiple oscillators warn of overbought conditions, and the high probability of a downside move suggests caution for new buyers. While price is holding near highs, technical resistance levels add further risk. "Without confirmation from momentum and further institutional support, I remain skeptical about sustained upside here."

Viktoras Karapetjanc, expert at Traders Union, views the upbeat financial results and strategic partnership as strong positives for Hims & Hers. He believes these developments reinforce fundamental strength and could drive continued investor interest. In his view, the bullish structure remains intact as long as price holds above key support levels. Market attention and improved outlook create setups for further growth on positive catalysts. "I see multiple opportunities for upside if momentum re-ignites and the story continues to gather institutional traction."

Parshwa Turakhiya, analyst, notes price action remains elevated thanks to news-driven buying, but technical signals are indecisive. He sees a short-term window for quick trades within the projected range between $28.69 and $33.45. Sentiment is active, but caution is warranted due to momentum divergence. "Traders should watch for a break of $31.63 to target quick moves, but respect the possibility of a swift reversal if sellers regain control."

Buyers sustain intraday highs as technical signals show mixed momentum

Hims & Hers is trading above its 20-day and 200-day moving averages at $30.26 and $28.71, respectively, but remains below the 50-day moving average at $32.17. This positioning indicates short- and long-term support persists, with medium-term sellers applying some pressure; the Ichimoku Kijun at $30.05 acts as additional support near current levels, while the near-term ceiling is at $31.63 and the floor at $30.26. Momentum readings are mixed: MACD and Average Directional Index (ADX) are both neutral, suggesting the trend is indecisive. The Relative Strength Index (RSI) is in neutral territory at 47.64 with a "Sell" forecast, while Stochastic RSI and Commodity Channel Index (CCI) are also neutral, indicating no definitive overbought or oversold condition. Bull/Bear Power (BBP) reads 0.97, confirming buyers dominate intraday momentum, but the BBP forecast signals overbought conditions. The stock has gained $1.24 or 4.16% intraday and opened with an upside gap of about $1.21 (4.06%). Price is holding near today's high with intraday volatility at 6.79%, showing strength toward highs. However, these gains come as several oscillators forecast selling, indicating a divergence between strong price action and mixed momentum signals.

Earlier, analysts noted that regulatory and technical risks had placed Hims & Hers in a bearish setup, with legal uncertainties adding further caution to the outlook. The latest price strength and positive guidance introduce a counterpoint to prior downside concerns, but traders should monitor for potential volatility as the stock tests resistance within the projected $28.69 to $33.45 range.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.